CardioPET is:

  • An F-18 labeled, modified fatty acid that provides insight into regions with decreased blood flow or metabolic insufficiency in the myocardium

CardioPET may be used to:

  • Identify patients that will benefit from PCI or revascularization and guide intervention
  • Assess myocardial viability
  • Evaluate CAD in patients that cannot exercise